Live feed08:00:00·311dPRReleasevia QuantisnowPivotal SAPPHIRE Trial Data Published in The Lancet Neurology: Apitegromab Demonstrated Significant Motor Function Gains for Children and Adults with SMA on SMN-Targeted TreatmentByQuantisnow·Wall Street's wire, on your screen.SRRK· Scholar Rock Holding CorporationHealth Care
